162 related articles for article (PubMed ID: 32671623)
1. Frequency of the TP53 p.R337H mutation in a Brazilian cohort of pediatric patients with solid tumors.
Feitosa JADS; das Chagas PF; de Sousa GR; Queiroz RGP; Cruzeiro GAV; Tone LG; Borges KS; Valera ET
Mol Biol Rep; 2020 Aug; 47(8):6439-6443. PubMed ID: 32671623
[TBL] [Abstract][Full Text] [Related]
2. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
[TBL] [Abstract][Full Text] [Related]
3. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
Ferreira AM; Brondani VB; Helena VP; Charchar HLS; Zerbini MCN; Leite LAS; Hoff AO; Latronico AC; Mendonca BB; Diz MDPE; de Almeida MQ; Fragoso MCBV
J Steroid Biochem Mol Biol; 2019 Jun; 190():250-255. PubMed ID: 30974190
[TBL] [Abstract][Full Text] [Related]
4. Increased incidence of choroid plexus carcinoma due to the germline TP53 R337H mutation in southern Brazil.
Custodio G; Taques GR; Figueiredo BC; Gugelmin ES; Oliveira Figueiredo MM; Watanabe F; Pontarolo R; Lalli E; Torres LF
PLoS One; 2011 Mar; 6(3):e18015. PubMed ID: 21445348
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of germline TP53 mutations and history of Li-Fraumeni syndrome in families with childhood adrenocortical tumors, choroid plexus tumors, and rhabdomyosarcoma: a population-based survey.
Magnusson S; Gisselsson D; Wiebe T; Kristoffersson U; Borg Å; Olsson H
Pediatr Blood Cancer; 2012 Nov; 59(5):846-53. PubMed ID: 22653678
[TBL] [Abstract][Full Text] [Related]
6. TP53 p.R337H is a conditional cancer-predisposing mutation: further evidence from a homozygous patient.
Giacomazzi J; Selistre S; Duarte J; Ribeiro JP; Vieira PJ; de Souza Macedo G; Rossi C; Czepielewski M; Netto CB; Hainaut P; Ashton-Prolla P
BMC Cancer; 2013 Apr; 13():187. PubMed ID: 23570263
[TBL] [Abstract][Full Text] [Related]
7. Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation.
Figueiredo BC; Sandrini R; Zambetti GP; Pereira RM; Cheng C; Liu W; Lacerda L; Pianovski MA; Michalkiewicz E; Jenkins J; Rodriguez-Galindo C; Mastellaro MJ; Vianna S; Watanabe F; Sandrini F; Arram SB; Boffetta P; Ribeiro RC
J Med Genet; 2006 Jan; 43(1):91-6. PubMed ID: 16033918
[TBL] [Abstract][Full Text] [Related]
8. Frequency of Thyroid Carcinoma in Brazilian TP53 p.R337H Carriers With Li Fraumeni Syndrome.
Formiga MNDC; de Andrade KC; Kowalski LP; Achatz MI
JAMA Oncol; 2017 Oct; 3(10):1400-1402. PubMed ID: 28114597
[TBL] [Abstract][Full Text] [Related]
9. Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors.
Custódio G; Parise GA; Kiesel Filho N; Komechen H; Sabbaga CC; Rosati R; Grisa L; Parise IZ; Pianovski MA; Fiori CM; Ledesma JA; Barbosa JR; Figueiredo FR; Sade ER; Ibañez H; Arram SB; Stinghen ST; Mengarelli LR; Figueiredo MM; Carvalho DC; Avilla SG; Woiski TD; Poncio LC; Lima GF; Pontarolo R; Lalli E; Zhou Y; Zambetti GP; Ribeiro RC; Figueiredo BC
J Clin Oncol; 2013 Jul; 31(20):2619-26. PubMed ID: 23733769
[TBL] [Abstract][Full Text] [Related]
10. The TP53 p.R337H mutation is uncommon in a Brazilian cohort of pediatric patients diagnosed with ependymoma.
de Almeida Magalhães T; Borges KS; de Sousa GR; Brandalise SR; Seidinger AL; Scrideli CA; Oba-Shinjo SM; Yunes JA; Tone LG
Neurol Sci; 2020 Mar; 41(3):691-694. PubMed ID: 31728854
[TBL] [Abstract][Full Text] [Related]
11. Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumors.
Mastellaro MJ; Seidinger AL; Kang G; Abrahão R; Miranda ECM; Pounds SB; Cardinalli IA; Aguiar SS; Figueiredo BC; Rodriguez-Galindo C; Brandalise SR; Yunes JA; Barros-Filho AA; Ribeiro RC
Cancer; 2017 Aug; 123(16):3150-3158. PubMed ID: 28387921
[TBL] [Abstract][Full Text] [Related]
12. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.
Achatz MI; Olivier M; Le Calvez F; Martel-Planche G; Lopes A; Rossi BM; Ashton-Prolla P; Giugliani R; Palmero EI; Vargas FR; Da Rocha JC; Vettore AL; Hainaut P
Cancer Lett; 2007 Jan; 245(1-2):96-102. PubMed ID: 16494995
[TBL] [Abstract][Full Text] [Related]
13. Association of the germline TP53 R337H mutation with breast cancer in southern Brazil.
Assumpção JG; Seidinger AL; Mastellaro MJ; Ribeiro RC; Zambetti GP; Ganti R; Srivastava K; Shurtleff S; Pei D; Zeferino LC; Dufloth RM; Brandalise SR; Yunes JA
BMC Cancer; 2008 Dec; 8():357. PubMed ID: 19046423
[TBL] [Abstract][Full Text] [Related]
14. Adrenocortical tumors associated with the TP53 p.R337H germline mutation can be identified during child-care consultations.
Mastellaro MJ; Ribeiro RC; Oliveira-Filho AG; Seidinger AL; Cardinalli IA; Miranda ECM; Aguiar SS; Brandalise SR; Yunes JA; Barros-Filho AA
J Pediatr (Rio J); 2018; 94(4):432-439. PubMed ID: 28864397
[TBL] [Abstract][Full Text] [Related]
15. Composite adrenal anaplastic neuroblastoma and virilizing adrenocortical tumor with germline TP53 R248W mutation.
Rossbach HC; Baschinsky D; Wynn T; Obzut D; Sutcliffe M; Tebbi C
Pediatr Blood Cancer; 2008 Mar; 50(3):681-3. PubMed ID: 17427234
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of an inherited cancer predisposition syndrome associated with the germ line TP53 R337H mutation in Paraguay.
Legal EF; Ascurra M; Custódio G; Ayala HL; Monteiro M; Vega C; Fernández-Nestosa MJ; Vega S; Sade ER; Coelho IM; Ribeiro EM; Cavalli IJ; Figueiredo BC
Cancer Epidemiol; 2015 Apr; 39(2):166-9. PubMed ID: 25736369
[TBL] [Abstract][Full Text] [Related]
17. Clinical and molecular characterization of patients fulfilling Chompret criteria for Li-Fraumeni syndrome in Southern Brazil.
Matzenbacher Bittar C; de Araújo Rocha YM; Vieira IA; Rosset C; Andreis TF; Sartor ITS; Artigalás O; Netto CBO; Alemar B; Macedo GS; Ashton-Prolla P
PLoS One; 2021; 16(9):e0251639. PubMed ID: 34529667
[TBL] [Abstract][Full Text] [Related]
18. Identification of the
Sandoval RL; Masotti C; de Macedo MP; Ribeiro MFSA; Leite ACR; Meireles SI; Bovolin RM; Santini FC; Munhoz RR; Jardim DLF; Katz A; Camargo AA; Fernandes GDS; Achatz MI
JCO Glob Oncol; 2021 Jul; 7():1141-1150. PubMed ID: 34270331
[TBL] [Abstract][Full Text] [Related]
19. The Common Germline
Jeffers JR; Pinto EM; Rehg JE; Clay MR; Wang J; Neale G; Heath RJ; Lozano G; Lalli E; Figueiredo BC; Pappo AS; Rodriguez-Galindo C; Chen W; Pounds S; Ribeiro RC; Zambetti GP
Cancer Res; 2021 May; 81(9):2442-2456. PubMed ID: 33637564
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of the TP53 p.R337H mutation in breast cancer patients in Brazil.
Giacomazzi J; Graudenz MS; Osorio CA; Koehler-Santos P; Palmero EI; Zagonel-Oliveira M; Michelli RA; Scapulatempo Neto C; Fernandes GC; Achatz MI; Martel-Planche G; Soares FA; Caleffi M; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
PLoS One; 2014; 9(6):e99893. PubMed ID: 24936644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
